158 related articles for article (PubMed ID: 29936785)
1. Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data.
Baghestani AR; Shahmirzalou P; Sayad S; Akbari ME; Zayeri F
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1601-1606. PubMed ID: 29936785
[TBL] [Abstract][Full Text] [Related]
2. Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center.
Baghestani AR; Zayeri F; Akbari ME; Shojaee L; Khadembashi N; Shahmirzalou P
Asian Pac J Cancer Prev; 2015; 16(17):7923-7. PubMed ID: 26625822
[TBL] [Abstract][Full Text] [Related]
3. Estimation of the cure rate in Iranian breast cancer patients.
Rahimzadeh M; Baghestani AR; Gohari MR; Pourhoseingholi MA
Asian Pac J Cancer Prev; 2014; 15(12):4839-42. PubMed ID: 24998549
[TBL] [Abstract][Full Text] [Related]
4. Application of a Non-Mixture Cure Rate Model for Analyzing Survival of Patients with Breast Cancer.
Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
Asian Pac J Cancer Prev; 2015; 16(16):7359-63. PubMed ID: 26514537
[TBL] [Abstract][Full Text] [Related]
5. Factors Affecting Long-Survival of Patients with Breast Cancer by Non-Mixture and Mixture Cure Models Using the Weibull, Log-logistic and Dagum Distributions: A Bayesian Approach.
Rafati S; Baneshi MR; Bahrampour A
Asian Pac J Cancer Prev; 2020 Feb; 21(2):485-490. PubMed ID: 32102528
[TBL] [Abstract][Full Text] [Related]
6. Survival Analysis of Patients with Breast Cancer using Weibull Parametric Model.
Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
Asian Pac J Cancer Prev; 2015; 16(18):8567-71. PubMed ID: 26745118
[TBL] [Abstract][Full Text] [Related]
7. Applying conventional and saturated generalized gamma distributions in parametric survival analysis of breast cancer.
Yavari P; Abadi A; Amanpour F; Bajdik C
Asian Pac J Cancer Prev; 2012; 13(5):1829-31. PubMed ID: 22901130
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis for white non-Hispanic female breast cancer patients.
Khan HM; Saxena A; Gabbidon K; Stewart TS; Bhatt C
Asian Pac J Cancer Prev; 2014; 15(9):4049-54. PubMed ID: 24935595
[TBL] [Abstract][Full Text] [Related]
9. Exploring factors related to metastasis free survival in breast cancer patients using Bayesian cure models.
Jafari-Koshki T; Mansourian M; Mokarian F
Asian Pac J Cancer Prev; 2014; 15(22):9673-8. PubMed ID: 25520087
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in patients with breast cancer referred to Cancer Research Center in Iran.
Baghestani AR; Shahmirzalou P; Zayeri F; Akbari ME; Hadizadeh M
Asian Pac J Cancer Prev; 2015; 16(12):5081-4. PubMed ID: 26163645
[TBL] [Abstract][Full Text] [Related]
11. Statistical estimates from black non-Hispanic female breast cancer data.
Khan HM; Ibrahimou B; Saxena A; Gabbidon K; Abdool-Ghany F; Ramamoorthy V; Ullah D; Stewart TS
Asian Pac J Cancer Prev; 2014; 15(19):8371-6. PubMed ID: 25339031
[TBL] [Abstract][Full Text] [Related]
12. Application of Cox and Parametric Survival Models to Assess Social Determinants of Health Affecting Three-Year Survival of Breast Cancer Patients.
Mohseny M; Amanpour F; Mosavi-Jarrahi A; Jafari H; Moradi-Joo M; Davoudi Monfared E
Asian Pac J Cancer Prev; 2016; 17(S3):311-6. PubMed ID: 27165244
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Weibull and Lognormal Cure Models with Cox in the Survival Analysis Of Breast Cancer Patients in Rafsanjan.
Hoseini M; Bahrampour A; Mirzaee M
J Res Health Sci; 2017 Feb; 17(1):e00369. PubMed ID: 28413171
[TBL] [Abstract][Full Text] [Related]
14. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors.
Hanrahan EO; Broglio KR; Buzdar AU; Theriault RL; Valero V; Cristofanilli M; Yin G; Kau SW; Hortobagyi GN; Rivera E
Cancer; 2005 Sep; 104(6):1158-71. PubMed ID: 16047352
[TBL] [Abstract][Full Text] [Related]
15. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.
Martín M; Ruiz A; Ruiz Borrego M; Barnadas A; González S; Calvo L; Margelí Vila M; Antón A; Rodríguez-Lescure A; Seguí-Palmer MA; Muñoz-Mateu M; Dorca Ribugent J; López-Vega JM; Jara C; Espinosa E; Mendiola Fernández C; Andrés R; Ribelles N; Plazaola A; Sánchez-Rovira P; Salvador Bofill J; Crespo C; Carabantes FJ; Servitja S; Chacón JI; Rodríguez CA; Hernando B; Álvarez I; Carrasco E; Lluch A
J Clin Oncol; 2013 Jul; 31(20):2593-9. PubMed ID: 23733779
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis in a Chinese population with T1-2N1 breast cancer: Did patients with 1 or 2, and 3 positive axillary lymph nodes have similar survival outcomes?
Shen H; Yuan J; Yang Y; Liu X; Wang L; Feng X; Zhao L; Niu Y
J Surg Oncol; 2015 Nov; 112(6):569-74. PubMed ID: 26458282
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Tausch C; Taucher S; Dubsky P; Seifert M; Reitsamer R; Kwasny W; Jakesz R; Fitzal F; Filipcic L; Fridrik M; Greil R; Gnant M
Ann Surg Oncol; 2012 Jun; 19(6):1808-17. PubMed ID: 22207051
[TBL] [Abstract][Full Text] [Related]
18. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
19. 5-Year Survival Rates and Prognostic Factors in Patients with Synchronus and Metachronus Breast Cancer from 2010 to 2015.
Sarveazad A; Babahajian A; Shamseddin J; Bahardoust M
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3489-3493. PubMed ID: 30583674
[TBL] [Abstract][Full Text] [Related]
20. Cure models for estimating hospital-based breast cancer survival.
Rama R; Swaminathan R; Venkatesan P
Asian Pac J Cancer Prev; 2010; 11(2):387-91. PubMed ID: 20843121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
